Drawing for RENALTX-SCORE

USPTO serial 87512222

RENALTX-SCORE

Reviewed by CopyMark Law Group

Reg. 5592067Status 704Registered
Filing date
Status date
Registration date
Oct 23, 2018
Examiner
TRUSILO, KELLY JEAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.

Status 704: Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active.

Need help with RENALTX-SCORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cecilia R. Dickson

Cecilia R. Dickson THE WEBB LAW FIRM420 Fort Duquesne Boulevard, Suite 1200One Gateway CenterPITTSBURGH, PA 15222

Goods and services

ClassDescriptionStatusFirst use
001[ Chemicals used in industry and science; chemical reagents other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; diagnostic reagents, other than for medical use for sale in kit form ]SECTION 8 - CANCELLED—
005[ Diagnostic preparations for medical or veterinary purposes; reagents for use in medical analysis; diagnostic reagents in kit form for medical purposes ]SECTION 8 - CANCELLED—
009Computer software, namely, analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, software for the operation of spectrometers, and software for evaluating the results of spectroscopic investigations and measurements; machine readable data carriers, namely, prerecorded magnetic or optical data carriers featuring analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, software for the operation of spectrometers, and software for evaluating the results of spectroscopic investigations and measurementsACTIVE—
042Development, programming and implementation of analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, software for the operation of spectrometers, and software for evaluating the results of spectroscopic investigations and measurements; scientific and technological services, namely, scientific and biotechnological testing services as well as medical and pharmacological research services in the fields of spectroscopy, of analyses of body fluids or their metabolites, of plant extracts and extracts of fermentation processes, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; medical and scientific laboratory services for analytical tests; working on and evaluation of chemical analyses; consultancy and providing information for the aforesaid servicesACTIVE—
044Medical services in the field of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; medical testing services for the analysis of samples taken from patients; medical analysis services for diagnosis and prognosis of diseases; consultancy and providing information for the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 11, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Aug 11, 20258.PRREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED—
Aug 8, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 23, 2025ES8RTEAS SECTION 8 RECEIVED—
Oct 23, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 23, 2018R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Sep 17, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 5, 2018ALIEASSIGNED TO LIE—
Aug 27, 2018ALIEASSIGNED TO LIE—
Aug 21, 2018ALIEASSIGNED TO LIE—
Aug 8, 2018CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Jul 23, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 23, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 16, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 16, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 26, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 26, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 28, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2017DOCKASSIGNED TO EXAMINER—
Jul 10, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 4, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance